Mednet Logo
HomeQuestion

Does high risk cytogenetics as a sole abnormality influence your treatment decision for smoldering multiple myeloma?

1 Answers
Mednet Member
Mednet Member
Medical Oncology · Harvard Medical School

Several studies have looked at the prognostic factor of FISH abnormalities and risk of progression of SMM to active disease (Neben et al., 2013; Rajkumar et al., 2013). Deletion 17p and t(4;14) are associated with the highest risk of progression, with median time to progression of 24 months, as repo...

Register or Sign In to see full answer